Premera Blue Cross December 2017 Medical Policy Updates

Click here to view the Premera Blue Cross Medical Policy Updates »

• 1.01.26 Cooling Devices Used in the Outpatient Setting
• 1.04.05 Microprocessor-Controlled Prostheses for the Lower Limb
• 12.04.102 Whole Exome and Whole Genome Sequencing for Diagnosis of Genetic Disorders
• 12.04.115 Expanded Molecular Panel Testing of Cancers to Identify Targeted Therapies
• 12.04.139 Genetic Testing for Heterozygous Familial Hypercholesterolemia
• 12.04.141 Circulating Tumor DNA and Circulating Tumor Cells for Cancer Management (Liquid Biopsy)
• 12.04.36 Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis In Patients With Breast Cancer
• 12.04.506 Genetic Testing for Lynch Syndrome and Other Inherited Colon Cancer Syndromes
• 12.04.63 Use of Common Genetic Variants (Single Nucleotide Polymorphisms) to Predict Risk of Non-familial Breast Cancer
• 12.04.93 Genetic Cancer Susceptibility Panels Using Next -Generation Sequencing
• 12.04.97 Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
• 2.01.17 Sublingual Immunotherapy as a Technique of Allergen-Specific Therapy
• 2.01.38 Transesophageal Endoscopic Therapies for Gastroesophageal Reflux Disease
• 2.03.502 Monoclonal Antibodies for the Treatment of B-Cell Malignancies
• 2.04.509 Cardiovascular Risk Panels
• 2.04.76 Quantitative Assay for Measurement of HER2 Total Protein Expression and HER2 Dimers
• 3.01.510 Applied Behavior Analysis (ABA)
• 3.01.515 Behavioral Health: Inpatient/Residential Detoxification 
• 5.01.19 Injectable Clostridial Collagenase for Fibroproliferative Disorders
• 5.01.500 Growth Hormone Therapy 
• 5.01.513 Xolair® (omalizumab)
• 5.01.519 Increlex® (mecasermin); Recombinant Human Insulin-Like Growth Factor-1
• 5.01.520 Antidepressants: Pharmacy Medical Necessity Criteria for Brands
• 5.01.521 Pharmacologic Treatment of Neuropathy, Fibromyalgia and Seizure Disorders
• 5.01.522 Advanced Therapies for Pharmacological Treatment of Pulmonary Arterial Hypertension 
• 5.01.534 Multiple Receptor Tyrosine Kinase Inhibitors
• 5.01.540 Miscellaneous Oral Oncology Drugs
• 5.01.545 Tadalafil (Cialis) for Benign Prostatic Hyperplasia
• 5.01.547 Medical Necessity Criteria and Dispensing Quantity Limits for Exchange Formulary Benefits
• 5.01.548 Pharmacotherapy of Cushing’s Disease and Acromegaly
• 5.01.552 Hetlioz® (tasimelteon)
• 5.01.556 Rituxan® (rituximab): Non-oncologic and Miscellaneous Uses
• 5.01.561 Repository Corticotropin Injection
• 5.01.605 Medical Necessity Criteria for Pharmacy Edits
• 6.01.23 Diagnosis and Treatment of Sacroiliac Joint Pain
• 6.01.46 Dynamic Spinal Visualization
• 6.01.54 Dopamine Transporter Imaging with Single -Photon Emission Computed Tomography 
• 7.01.131 Transcatheter Pulmonary Valve Implantation 
• 7.01.20 Vagus Nerve Stimulation 
• 7.01.516 Bariatric Surgery
• 7.01.554 Surgical Treatment of Snoring and Obstructive Sleep Apnea Syndrome
• 7.01.555 Facet Joint Denervation
• 7.01.562 Intraoperative Neurophysiologic Monitoring
• 8.01.22 Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias
• 8.01.519 Treatment of Hyperhidrosis 
• 8.01.529 Hematopoietic Stem-Cell Transplantation for Non-Hodgkin Lymphomas
• 8.02.02 Plasma Exchange

Click here to view the Premera Blue Cross Medical Policy Updates »

Policy Alerts monitors Commercial and Medicare medical policies for changes. While Payers typically update medical policies annually, there are many reasons why a Payer might review or update a policy. When reviews occur out of cycle, they may go unnoticed. Policy Alerts keeps you informed of upcoming and unexpected coverage changes affecting your product. Quickly understanding the changes Payers make can help you adjust reimbursement strategies impacting your business.

Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on Payer decisions in real-time. Whenever changes occur, email notifications containing a summary of those changes are delivered to your inbox. Clients can access detailed coverage reports and medical policies on the interactive Dashboard portal. Save time and keep focused on the important Payer medical policy reviews and coverage decisions affecting your product!

Policy Alerts takes a client-focused hands-on approach and works hard to provide our customers with helpful insights and actionable analytics over raw data. We understand what our clients need and we are dedicated to making sure we provide timely, accurate and always up-to-date reports that can be used to implement and support a successful reimbursement strategy.

Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.